Catalent Cts Inc Kansas City, MO - 64137

Catalent Cts Inc is categorized under Commercial Biotechnical Research in Kansas City, MO and active since 2011.

Catalent Cts Inc was established in 2011, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.

If you are seeking more information, feel free to contact Timothy C Tyson at the company’s headquarters by writing to 10245 Hickman Mills Drive, Kansas City, Missouri MO 64137 or by phoning (816) 767-6000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Catalent Cts Inc
Contact Person: Timothy C Tyson
Address: 10245 Hickman Mills Drive, Kansas City, Missouri 64137
Phone Number: (816) 767-6000
Website Address: catalent.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founded: 2011
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Biotechnical Research
SIC Code: 8731
NAICS Code: 541711
Share This Business:

Catalent Cts Inc was started in 2011 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.

Feel free to contact Timothy C Tyson for inquiries that concern Catalent Cts Inc by calling the company number (816) 767-6000, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Catalent Cts Inc can be found at the coordinates 38.940357,-94.534065 as well as the street address 10245 Hickman Mills Drive in Kansas City, Missouri 64137.

For its online presence, you may visit Catalent Cts Inc’s website at catalent.com and engage with its social media outlets through on Twitter and on Facebook.